
Illuccix gets approval in the UK to improve prostate cancer detection
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the Marketing Authorisation Application for Telix Pharmaceuticals’ prostate cancer PET imaging agent, Illuccix. The agent is indicated in the UK for the detection and …